About Karolinska Institutet Holding
Karolinska Institutet Holding operates as a holding company. The company, through its subsidiaries, manages stocks in research and development companies, as well as offers infrastructure for newly started companies, administrative, legal, and financial services. The company is based in Solna, Sweden.
Missing: Karolinska Institutet Holding's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: Karolinska Institutet Holding's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Latest Karolinska Institutet Holding News
Sep 12, 2022
Pretzel Therapeutics, a biotechnology company harnessing the intricacies of mitochondrial biology to develop groundbreaking therapies, launched with a $72.5 million Series A financing to pioneer novel therapies to modulate mitochondrial function. The financing was led by ARCH Venture Partners and Mubadala Capital with participating investors HealthCap, Cambridge Innovation Capital, Cambridge Enterprise, Angelini Ventures, GV, Invus, Eir Ventures, GU Ventures, and Karolinska Institutet Holding. (c)2011-2020 by Massinvestor, Inc. For contact info, please check out our about page.
Karolinska Institutet Holding Frequently Asked Questions (FAQ)
Where is Karolinska Institutet Holding's headquarters?
Karolinska Institutet Holding's headquarters is located at Nanna Svartz vag 6A, Solna.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.